PYCPYC Therapeutics Limited

PYC Stock Price, Valuation & Chart | PYC Therapeutics Limited

Compare

$2.430+0.14 (+6.11%)

At close · 02 Sept 2026, 06:10 am

Sector: Healthcare Industry: Biotechnology PYC intrinsic value PYC calculated fair value vs price Website

Overview Financials Dividends Ratios

PYC Historical price chart

PYC Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.42B

PE Ratio-53.29

EPS-0.05

Trading Volume8.72M

Today's High/Low2.43/2.27

Dividend Yield0.00

52 Week High/Low2.43/0.85

Shares Outstanding583.05M

PYC Financial Statement

PYC Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 5 analysts giving stock ratings to PYC in the past 3 months.

PYC Analysis & performance metrics

PYC Company profile

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia.…

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the…

PYC Management team

Name

Position

Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A.

Company Secretary

Andrew Taylor B.Com., C.A.CFO

Chief Financial Officer & Company Secretary

Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)CEO

Chief Executive Officer & Executive Director

Name

Position

Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A.

Company Secretary

Andrew Taylor B.Com., C.A.CFO

Chief Financial Officer & Company Secretary

Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)CEO

Chief Executive Officer & Executive Director

Management Team

Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A.

Company Secretary

Andrew Taylor B.Com., C.A.CFO

Chief Financial Officer & Company Secretary

Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)CEO

Chief Executive Officer & Executive Director

Management

Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A.

Company Secretary

Andrew Taylor B.Com., C.A.CFO

Chief Financial Officer & Company Secretary

Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)CEO

Chief Executive Officer & Executive Director

Total 3 executives

PYC Frequently asked questions

What is PYC Therapeutics Limited (PYC) Stock Price?

Current stock price of PYC Therapeutics Limited (PYC) stock is $2.430. The stock price is +6.11% higher in the session. The intraday range can be seen from this page. Volume of PYC Therapeutics Limited (PYC) stock is 8.72M.

Last updated at 02 Sept 2026, 06:10 am.

Why is the PYC Therapeutics Limited (PYC) stock price going up or down today?

The stock price of PYC Therapeutics Limited (PYC) can change with earnings, company news, and overall market sentiment. PYC Therapeutics Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the PYC Therapeutics Limited stock expensive at its current price?

Whether PYC Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PYC on this page is -53.29. EPS on this page is -0.05. Compare those figures with peers and growth expectations before deciding if the current PYC Therapeutics Limited price is justified.

How has the stock price of PYC Therapeutics Limited (PYC) performed historically?

Historical performance for PYC Therapeutics Limited (PYC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PYC reacted to past earnings and market events.

Should I buy PYC Therapeutics Limited (PYC) stock, at this price?

Buying PYC Therapeutics Limited (PYC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.